查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945426

2026年全球静脉输液治疗解决方案市场报告

Intravenous Therapy Solutions Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，静脉输液市场发展迅速，预计将从2025年的131.7亿美元成长到2026年的145.3亿美元，复合年增长率（CAGR）为10.3%。过去几年的增长可归因于多种因素，例如医院基础设施的扩建、脱水和电解质失衡的患病率上升、静脉输液疗法在临床上的应用日益广泛、静脉输液技术的进步以及外科手术数量的增加。

预计未来几年，静脉输液治疗市场将强劲成长，2030年市场规模将达212.5亿美元，复合年增长率（CAGR）为10.0%。预测期内的成长要素包括：居家医疗的日益普及、对个人化营养和药物管理需求的成长、与数位健康平台的技术整合、新兴市场的扩张以及慢性病管理技术的进步。预测期内的主要趋势包括：个人化静脉输液治疗方案、携带式和家用静脉注射设备、感染控制和安全性的提升、先进的电解质和营养配方以及与电子健康记录（EHR）的整合。

预计对微创手术日益增长的需求将推动静脉输液治疗市场的成长。微创手术是指对身体切口或侵入量极小的医疗程序，通常可缩短恢復时间并减少併发症。这种成长趋势源自于微创手术的特性，这些手术能够减轻术后疼痛、加速恢復速度并提高患者在復原过程中的舒适度。静脉输液治疗透过将液体、药物和营养物质直接输送到血液中，从而实现这些治疗，有助于提高患者照护效果并加速康復。例如，根据美国整形外科医师协会2024年6月发布的数据，2023年微创手​​术的数量年增7%，比外科手术的整体成长率高出2%。因此，对微创手术日益增长的需求正在推动静脉输液治疗市场的成长。

静脉输液治疗市场的主要企业正致力于开发创新产品，例如即用型输液，以提高治疗效率并缩短临床环境中的配药时间。即用型输液是预先混合、预先贴标的静脉注射药物，以标准化剂量包装，无需现场稀释或配製。 2024年5月，美国製造商贝朗医疗公司（B. Braun Medical Inc.）推出了“氯化钠注射液中的左乙拉西坦”，这是一种用于治疗癫痫发作的即用型静脉抗惊厥溶液。该产品以标准化的浓度和容量提供，无需在护理点进行稀释或配製。该製剂预先混合在柔性容器中，确保剂量准确并降低污染风险，从而为急诊和住院患者照护环境中的医护人员带来便利。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球静脉输液治疗方案市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
    • 永续性、气候技术和循环经济
  • 主要趋势
    • 个人化静脉输液治疗方案
    • 携带式和家用输液装置
    • 感染控制和安全改进
    • 高级电解质和营养配方
    • 电子健康记录 (EHR) 集成

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 门诊手术中心
  • 居家医疗机构
  • 专业医疗中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球静脉输液治疗解决方案市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球静脉输液治疗解决方案市场规模、对比及成长率分析
  • 全球静脉输液治疗解决方案市场表现：规模与成长，2020-2025年
  • 全球静脉输液治疗解决方案市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依产品类型
  • 晶体液、胶体液、血液製品及其他产品类型
  • 透过使用
  • 体液和电解质失衡、营养支持、药物输注、输血及其他用途
  • 最终用户
  • 医院、诊所、门诊手术中心、居家医疗机构和其他最终用户
  • 按类型细分：晶体溶液
  • 生理食盐水水（0.9%氯化钠溶液）、半体积生理食盐水（0.45%氯化钠溶液）、乳酸林格氏液、葡萄糖溶液、高渗透压盐水
  • 按类型细分：胶体製剂
  • 白蛋白、聚葡萄糖、羟乙基淀粉（HES）、明胶
  • 按类型细分：血液製品
  • 浓缩红血球（PRBC）、血小板、新鲜冷冻血浆（FFP）、冷沉淀
  • 按类型细分：其他产品类型
  • 静脉注射免疫球蛋白（IVIG）、肠外营养、特殊静脉注射药物及添加剂

第十章 区域与国家分析

  • 全球静脉输液市场：区域分析、预测与趋势，2020-2025年、2025-2030年预测、2035年预测
  • 全球静脉输液治疗解决方案市场：国家/地区、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 静脉输液治疗方案市场：竞争格局及市场占有率（2024年）
  • 静脉输液治疗方案市场：公司估值矩阵
  • 静脉输液治疗方案市场：公司概况
    • Pfizer Inc.
    • Otsuka Pharmaceutical Co. Ltd.
    • Baxter International Inc.
    • Fresenius Kabi AG
    • Grifols SA

第37章：其他领先和创新企业

  • Terumo Corporation, Dr. Reddy's Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited, Amanta Healthcare Limited, Aculife Healthcare Private Limited, Claris Lifesciences Limited

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年静脉输液治疗市场：提供新机会的国家
  • 2030年静脉输液治疗市场：新兴细分市场机会
  • 2030年静脉输液治疗市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MITSH01_G26Q1

Intravenous therapy solutions are sterile liquid formulations administered directly into the bloodstream to deliver fluids, medications, nutrients, or electrolytes. These solutions are used to treat conditions such as dehydration, electrolyte imbalances, infections, and to provide essential nutrients when oral intake is not feasible. Typically composed of water, salts, sugars, or medicinal ingredients, they are customized based on individual patient requirements and specific medical conditions.

The primary types of intravenous therapy solutions include crystalloids, colloids, blood products, and others. Crystalloids consist of water mixed with electrolytes and are commonly used for rapid rehydration and fluid balance restoration in urgent medical situations. These solutions serve multiple purposes, including correcting fluid and electrolyte imbalances, supporting nutrition, administering medications, and enabling blood transfusions. They are utilized across a range of healthcare settings, including hospitals, clinics, ambulatory surgical centers, home care environments, and more.

Tariffs are impacting the intravenous therapy solutions market by increasing the cost of imported raw materials such as saline, glucose, and specialty nutrients, leading to higher production costs for manufacturers. The segments most affected include crystalloids and colloids, particularly in regions like North America and Europe, which rely on imports from Asia-Pacific. While tariffs have posed challenges in supply chain efficiency, they have also encouraged local manufacturing and innovation, creating opportunities for domestic production of cost-effective intravenous solutions.

The intravenous therapy solutions market research report is one of a series of new reports from The Business Research Company that provides intravenous therapy solutions market statistics, including intravenous therapy solutions industry global market size, regional shares, competitors with a intravenous therapy solutions market share, detailed intravenous therapy solutions market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous therapy solutions industry. This intravenous therapy solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous therapy solutions market size has grown rapidly in recent years. It will grow from $13.17 billion in 2025 to $14.53 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to growing hospital infrastructure, rising incidence of dehydration and electrolyte imbalance, increasing adoption of iv therapy in clinics, technological advancements in iv solutions, rising surgical procedures.

The intravenous therapy solutions market size is expected to see strong growth in the next few years. It will grow to $21.25 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing home healthcare adoption, rising demand for personalized nutrition and medication administration, technological integration with digital health platforms, expansion in emerging markets, growth in chronic disease management. Major trends in the forecast period include personalized iv therapy solutions, portable and home-based iv devices, infection control and safety enhancements, advanced electrolyte and nutrient formulations, integration with electronic health records (ehr).

The increasing demand for minimally invasive therapies is expected to drive growth in the intravenous therapy solutions market. Minimally invasive therapies involve medical treatments with minimal incisions or bodily entry, often resulting in quicker recovery and fewer complications. This rising preference is attributed to the therapies' ability to reduce postoperative pain, leading to faster recovery and greater patient comfort during healing. Intravenous therapy solutions facilitate these treatments by delivering fluids, medications, and nutrients directly into the bloodstream, promoting effective patient care and accelerated recovery. For example, in June 2024, the American Society of Plastic Surgeons reported that minimally invasive procedures increased by 7% in 2023, surpassing the growth rate of surgical procedures by 2%. Hence, the rising demand for minimally invasive therapies is fueling the expansion of the intravenous therapy solutions market.

Key players in the intravenous therapy solutions market are focusing on innovative products such as ready-to-use drug infusions to improve treatment efficiency and reduce preparation time in clinical environments. Ready-to-use drug infusions consist of pre-mixed and pre-labeled intravenous medications packaged in standardized doses, eliminating the need for on-site dilution or compounding. In May 2024, B. Braun Medical Inc., a US-based manufacturer, introduced Levetiracetam in Sodium Chloride Injection, a ready-to-use intravenous anticonvulsant solution designed for seizure treatment. This product comes in standardized concentrations and volumes, removing the requirement for dilution or compounding at the point of care. The formulation is pre-mixed in a flexible container to ensure dosing accuracy, reduce contamination risks, and improve convenience for healthcare providers in emergency and inpatient settings.

In April 2025, Organon & Co., a US-based healthcare company, acquired the regulatory and commercial rights to Tofidence from Biogen Inc. This acquisition aims to strengthen and expand Organon & Co.'s biosimilars immunology portfolio in the US by including Tofidence to support treatments for multiple arthritis conditions and COVID-19. The company plans to leverage its commercial expertise and market access capabilities to foster long-term growth in the immunology sector. Biogen Inc. is a US-based biotechnology firm specializing in intravenous therapy solutions like Tofidence.

Major companies operating in the intravenous therapy solutions market are Pfizer Inc., Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy's Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited, Amanta Healthcare Limited, Aculife Healthcare Private Limited, Claris Lifesciences Limited, Osel Lifesciences Pvt. Ltd., BBraun Avitum AG

North America was the largest region in the intravenous therapy solutions market in 2025. The regions covered in the intravenous therapy solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intravenous therapy solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The intravenous therapy solutions market consists of sales of saline solutions, dextrose solutions, lactated Ringer's solutions, amino acid solutions, vitamin and mineral infusions, IV antibiotic solutions, chemotherapy IV solutions, and parenteral nutrition solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous Therapy Solutions Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses intravenous therapy solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous therapy solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous therapy solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Crystalloids; Colloids; Blood Products; Other Product Types
  • 2) By Application: Fluid And Electrolyte Imbalance; Nutritional Support; Medication Administration; Blood Transfusion; Other Applications
  • 3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Home Care Settings; Other End-Users
  • Subsegments:
  • 1) By Crystalloids: Normal Saline (0.9% Sodium Chloride); Half Normal Saline (0.45% Sodium Chloride); Lactated Ringer's Solution; Dextrose Solutions; Hypertonic Saline
  • 2) By Colloids: Albumin; Dextran; Hydroxyethyl Starch (HES); Gelatin
  • 3) By Blood Products: Packed Red Blood Cells (PRBCs); Platelets; Fresh Frozen Plasma (FFP); Cryoprecipitate
  • 4) By Other Product Types: Intravenous Immunoglobulins (IVIG); Parenteral Nutrition Solutions; Specialty Intravenous Drugs And Additives
  • Companies Mentioned: Pfizer Inc.; Otsuka Pharmaceutical Co. Ltd.; Baxter International Inc.; Fresenius Kabi AG; Grifols S.A.; Terumo Corporation; Dr. Reddy's Laboratories Limited; Sichuan Kelun Pharmaceutical Co. Ltd.; Hikma Pharmaceuticals PLC; Biocon Limited; B. Braun Melsungen Aktiengesellschaft; JW Life Science Corporation; AdvaCare Pharma USA; Soxa Formulations & Research Pvt. Ltd.; Vifor Pharma Management Ltd.; Aetos Pharma Private Limited; LXIR Medilabs Private Limited; Amanta Healthcare Limited; Aculife Healthcare Private Limited; Claris Lifesciences Limited; Osel Lifesciences Pvt. Ltd.; BBraun Avitum AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Intravenous Therapy Solutions Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Intravenous Therapy Solutions Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Intravenous Therapy Solutions Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Intravenous Therapy Solutions Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Personalized Iv Therapy Solutions
    • 4.2.2 Portable And Home-Based Iv Devices
    • 4.2.3 Infection Control And Safety Enhancements
    • 4.2.4 Advanced Electrolyte And Nutrient Formulations
    • 4.2.5 Integration With Electronic Health Records (Ehr)

5. Intravenous Therapy Solutions Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Home Care Settings
  • 5.5 Specialty Care Centers

6. Intravenous Therapy Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Intravenous Therapy Solutions Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Intravenous Therapy Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Intravenous Therapy Solutions Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Intravenous Therapy Solutions Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Intravenous Therapy Solutions Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Intravenous Therapy Solutions Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Intravenous Therapy Solutions Market Segmentation

  • 9.1. Global Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Crystalloids, Colloids, Blood Products, Other Product Types
  • 9.2. Global Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications
  • 9.3. Global Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users
  • 9.4. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Crystalloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer's Solution, Dextrose Solutions, Hypertonic Saline
  • 9.5. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Colloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Albumin, Dextran, Hydroxyethyl Starch (HES), Gelatin
  • 9.6. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Blood Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate
  • 9.7. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs And Additives

10. Intravenous Therapy Solutions Market Regional And Country Analysis

  • 10.1. Global Intravenous Therapy Solutions Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Intravenous Therapy Solutions Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Intravenous Therapy Solutions Market

  • 11.1. Asia-Pacific Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Intravenous Therapy Solutions Market

  • 12.1. China Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Intravenous Therapy Solutions Market

  • 13.1. India Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Intravenous Therapy Solutions Market

  • 14.1. Japan Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Intravenous Therapy Solutions Market

  • 15.1. Australia Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Intravenous Therapy Solutions Market

  • 16.1. Indonesia Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Intravenous Therapy Solutions Market

  • 17.1. South Korea Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Intravenous Therapy Solutions Market

  • 18.1. Taiwan Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Intravenous Therapy Solutions Market

  • 19.1. South East Asia Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Intravenous Therapy Solutions Market

  • 20.1. Western Europe Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Intravenous Therapy Solutions Market

  • 21.1. UK Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Intravenous Therapy Solutions Market

  • 22.1. Germany Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Intravenous Therapy Solutions Market

  • 23.1. France Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Intravenous Therapy Solutions Market

  • 24.1. Italy Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Intravenous Therapy Solutions Market

  • 25.1. Spain Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Intravenous Therapy Solutions Market

  • 26.1. Eastern Europe Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Intravenous Therapy Solutions Market

  • 27.1. Russia Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Intravenous Therapy Solutions Market

  • 28.1. North America Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Intravenous Therapy Solutions Market

  • 29.1. USA Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Intravenous Therapy Solutions Market

  • 30.1. Canada Intravenous Therapy Solutions Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Intravenous Therapy Solutions Market

  • 31.1. South America Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Intravenous Therapy Solutions Market

  • 32.1. Brazil Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Intravenous Therapy Solutions Market

  • 33.1. Middle East Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Intravenous Therapy Solutions Market

  • 34.1. Africa Intravenous Therapy Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Intravenous Therapy Solutions Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Intravenous Therapy Solutions Market Regulatory and Investment Landscape

36. Intravenous Therapy Solutions Market Competitive Landscape And Company Profiles

  • 36.1. Intravenous Therapy Solutions Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Intravenous Therapy Solutions Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Intravenous Therapy Solutions Market Company Profiles
    • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Intravenous Therapy Solutions Market Other Major And Innovative Companies

  • Terumo Corporation, Dr. Reddy's Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited, Amanta Healthcare Limited, Aculife Healthcare Private Limited, Claris Lifesciences Limited

38. Global Intravenous Therapy Solutions Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Intravenous Therapy Solutions Market

40. Intravenous Therapy Solutions Market High Potential Countries, Segments and Strategies

  • 40.1 Intravenous Therapy Solutions Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Intravenous Therapy Solutions Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Intravenous Therapy Solutions Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer